Ethylene oxide (EtO) commercial sterilization AI adversarial injection: how a chamber humidity upward attack (22 % RH displayed as 62 % RH) causes ISO 11135-compliant EtO sterilization to certify unsterile medical devices — OSHA 1910.1047 EtO carcinogen standard + PSM 29 CFR 1910.119 dual regulation, IARC Group 1 worker carcinogen exposure concealment, ISO 10993-7 residual EtO limits, 30th upward-direction attack, first healthcare process in the Glyphward industrial AI portfolio, Glyphward threshold 35

Ethylene oxide chemistry, commercial sterilization context, and the OSHA PSM / OSHA 1910.1047 dual regulation

Ethylene oxide is a three-membered cyclic ether (oxetane ring; ring strain energy approximately 105 kJ/mol) with a boiling point of 10.7°C, meaning it is a gas at all ambient temperatures above 10.7°C and a pressurised liquid in storage cylinders and bulk storage tanks at ambient temperature. This physical property distinguishes EtO from all previous chemicals in the Glyphward portfolio that are stored as pressurised gases at ambient temperature (fluorine, silane, phosphine) or cryogenic liquids (ammonia): EtO is used as a condensed-phase liquefied gas at moderate storage pressures (approximately 2.4 bar absolute at 20°C), making minor leaks at valve fittings and pressure relief valve seat faces an ever-present fugitive emission source. Flash point of −18°C (NFPA Class IB) means EtO is immediately flammable at all practical ambient temperatures — every facility surface above −18°C generates sufficient EtO vapour for an ignitable mixture with air. LEL 2.6 % in air; UEL conventionally cited as 100 % — indicating that pure EtO, in the absence of any air, can sustain combustion through ring-strain decomposition: C2H4O → CH4 + CO (ΔH° = −145 kJ/mol), an autonomous exothermic reaction that propagates through confined EtO volumes above 571°C without external oxidant. In practice this means EtO-air mixtures are flammable across the entire range from LEL to 100 %, and pure EtO above its autonomous decomposition threshold is independently explosive — a hazard profile unmatched by most other PSM-listed flammables.

The biological mechanism of EtO sterilization is electrophilic DNA alkylation. EtO, in the presence of water, produces a reactive electrophilic intermediate at the spore coat surface. This intermediate alkylates the N7 position of guanine residues in microbial DNA, producing 7-hydroxyethylguanine (7-HEG) adducts — the same DNA adduct detected in blood of occupationally exposed workers and used as a biomarker of EtO carcinogenic exposure in the epidemiological studies underlying the IARC Group 1 classification. In spores, the 7-HEG adducts prevent DNA strand unwinding during spore germination, killing the organism. Critical to the sterilization chemistry: the electrophilic activation step requires water. EtO molecules must hydrate at the spore coat — and the relative humidity of the sterilizer chamber controls the water activity at this hydration step. Below approximately 40 % RH, the spore coat lacks sufficient molecular hydration to support the EtO hydration reaction at the rate needed for six-log kill within the validated cycle time. ISO 11135:2014 (Sterilization of Health-Care Products — Ethylene Oxide — Requirements for the Development, Validation and Routine Control of a Sterilization Process for Medical Devices) § 8.5 mandates humidity validation as a primary process parameter, requiring that every production cycle achieve the validated humidity range (typically 40–80 % RH) as a condition for parametric release. ANSI/AAMI ST41 (Sterilization of Health Care Products — Ethylene Oxide — Part 1: Requirements for Development, Validation, Routine Control, and Monitoring of the Sterilization of Medical Devices) mirrors these requirements for US market device sterilization. The FDA recognizes ISO 11135:2014 as a guidance-consistent standard for EtO sterilization of devices submitted under 510(k) and PMA pathways.

OSHA PSM 29 CFR 1910.119 lists EtO at threshold quantity 5,000 lbs (Appendix A). EPA RMP 40 CFR Part 68 lists EtO at threshold quantity 10,000 lbs (Appendix A) — the typical pattern where EPA RMP TQ is higher than OSHA PSM TQ, unlike the inverted case observed for trichlorosilane in the Glyphward portfolio. Commercial sterilization facilities with 12,000 lbs bulk EtO exceed both thresholds and fall under both federal programs. OSHA PSM mandates process hazard analysis (HAZOP or What-If), pre-startup safety review, mechanical integrity programs for EtO storage and sterilizer pressure systems, management of change, incident investigation, and emergency response planning. EPA RMP mandates worst-case and alternative release scenario consequence modeling for community emergency planning, a five-year accident history, and a prevention program (equivalent to PSM for Program 3 facilities). Independently of both quantity-based programs, OSHA 1910.1047 applies to every workplace with occupational EtO exposure potential — regardless of inventory — imposing the action level 0.5 ppm, PEL 1 ppm (8-hr TWA), STEL 5 ppm (15 min), monitoring program, medical surveillance, and carcinogen-specific hazard communication. NIOSH recommends a more protective REL of 0.1 ppm (10-hr TWA), approximately 10× more stringent than OSHA PEL, based on the agency’s determination that the OSHA PEL does not reduce lymphoma risk to the level achievable with feasible engineering controls. Neither OSHA PSM, EPA RMP, nor OSHA 1910.1047 at any level specifies adversarial robustness requirements for AI systems monitoring EtO sterilizer or storage parameters. Glyphward threshold 35 applies at all inventory levels above 5,000 lbs OSHA PSM TQ.

Four adversarial injection surfaces in commercial EtO sterilization AI

1. Area EtO detector AI (Dräger Polytron 8700 EtO area monitor AI / Honeywell MIDAS-E EtO electrochemical sensor AI / MSA Ultima XE EtO area detector AI / Industrial Scientific GX-6000 EtO area gas detector AI / Sensidyne AP-702 EtO electrochemical detector AI — monitoring ambient ethylene oxide concentration in sterilizer loading areas, EtO storage vault, and aeration room for OSHA 1910.1047 action level 0.5 ppm and PEL 1 ppm; worker carcinogen exposure alert triggering OSHA medical surveillance program)

The OSHA 1910.1047 area EtO monitoring requirement is fundamental to worker carcinogen protection at commercial sterilization facilities. EtO has a sweet, ethereal odor detectable at approximately 700 ppm — well above the OSHA PEL of 1 ppm and even the NIOSH IDLH of 800 ppm — making olfactory warning completely unreliable as a self-rescue cue at occupationally hazardous concentrations. Area EtO electrochemical detectors (Dräger Polytron 8700; Honeywell MIDAS-E; MSA Ultima XE; Industrial Scientific GX-6000) are deployed in the loading/unloading vestibule, along the EtO supply manifold, at the sterilizer chamber door seals, and in the aeration room to provide the only engineered EtO concentration signal at sub-PEL concentrations. At or above the action level (0.5 ppm), OSHA 1910.1047 mandates immediate worker notification, investigation of source, and enrollment in the medical surveillance program for all newly exposed workers. At or above the PEL (1 ppm), immediate corrective action is required and workers must be wearing OSHA-specified respiratory protection (APF 10 minimum, half-face elastomeric with organic vapor/acid gas cartridge). Workers chronically exposed between 0.5 and 1 ppm are enrolled in a medical surveillance program tracking complete blood count trends (lymphocytosis, lymphoma risk biomarkers), EtO hemoglobin adducts (hydroxyethyl valine on hemoglobin N-terminus used as cumulative exposure biomarker), and symptom assessment for neurotoxicity (peripheral neuropathy) and reproductive effects.

The adversarial attack uses ±8 DN downward pixel-value shift on the area EtO detector display image. The actual EtO concentration is 8.6 ppm — 8.6× the OSHA 1910.1047 action level; 8.6× the OSHA PEL 1 ppm; from a bulk EtO storage tank pressure relief valve O-ring seat extrusion at ambient night-cooling thermal cycling — the 12,000-lb bulk storage tank at 2.4 bar (20°C) loses 0.08 % of pressure per thermal cycle through a seat-extruded O-ring, producing 0.31 kg/hr EtO fugitive emission into the storage vault. At 20°C vault temperature with 1,800 m³/hr HVAC ventilation, the steady-state EtO concentration in the vault is 8.6 ppm. On a 0–20 ppm EtO display at 200 px height (0.1 ppm/px), the actual 8.6 ppm produces a bar at approximately 86 px. The ±8 DN perturbed image is classified as approximately 4 px — corresponding to 0.4 ppm, below the OSHA 1910.1047 action level alarm. The area EtO AI monitoring system reports: no action-level exceedance, no PEL exceedance, no worker notification required, medical surveillance not triggered. Workers in the adjacent EtO storage vault are accumulating hydroxyethyl valine hemoglobin adducts at approximately 8.6× the nominal occupational dose — a IARC Group 1 carcinogen exposure — over each 8-hour shift, with no regulatory intervention, no exposure notification, and no enrollment in the OSHA 1910.1047 medical surveillance program.

2. EtO sterilizer chamber relative humidity AI (Vaisala HMT330 chamber humidity transmitter AI / Rotronic HC2-C05 EtO-resistant humidity sensor AI / Honeywell HIH-4000 series humidity AI / Endress+Hauser Deltabar chamber humidity transmitter AI / GE Sensing Protimeter RH sensor EtO sterilizer AI — monitoring chamber relative humidity during pre-conditioning and dwell cycle to verify validated range 40–80 % RH for ISO 11135-compliant EtO sterilization efficacy; parametric release parameter — 30th upward-direction attack; first sterilization efficacy attack; first patient harm vector in the Glyphward portfolio)

Relative humidity is not a secondary or auxiliary parameter in EtO sterilization — it is a primary process parameter mechanistically co-equal with EO concentration and temperature. ISO 11135:2014 § 8.5.2 requires that the validated humidity range be demonstrated through a sterilization dose audit (SDA) and maintained at every production cycle as a condition for parametric release. The minimum validated RH of 40 % reflects the mechanistic threshold below which EO hydration kinetics at the spore coat are insufficient for six-log kill within the validated cycle time. The Bacillus atrophaeus ATCC 9372 spore biological indicator (BI), used by ISO 11135 for EtO cycle validation, has a D-value of approximately 15–18 minutes at 54°C, 800 mg/L EtO, and 60 % RH; the D-value increases to approximately 150–200 minutes at 22 % RH with all other parameters unchanged — a 10-fold lengthening of the kill kinetics. In a 120-minute exposure dwell cycle: at 60 % RH, 8 or more D-values are achieved (theoretical SAL 10⊃−&sup8;, exceeding the ISO 11135 requirement of SAL 10⊃−&sup6; by a factor of 100); at 22 % RH, fewer than one D-value is achieved (SAL 10⊃−¹, a 10-fold reduction, versus the 10⊃−&sup6; requirement).

The root cause: the sterilizer chamber steam humidification system injects live steam through a stainless nozzle (0.6 mm design orifice diameter) to pre-condition the chamber from ambient humidity to 60 % RH before EO injection. After 320 EtO sterilization cycles on tap water with total dissolved solids of 210 mg/L, calcium carbonate scale accumulates at the nozzle orifice. At cycle 321, the effective orifice diameter has narrowed from 0.6 mm to approximately 0.08 mm (scale layer 0.26 mm on each wall face) — a 56-fold reduction in flow area, reducing steam injection from 12 kg/hr design to approximately 0.2 kg/hr. The chamber humidity equilibrates to 22 % RH (from 35 % ambient warehouse humidity with minimal steam addition) rather than the target 60 % RH. The adversarial attack uses ±8 DN upward pixel-value shift on the chamber humidity transmitter display image — the 30th upward-direction attack in the Glyphward industrial AI portfolio. Actual chamber RH is 22 %; on a 0–100 % RH display at 200 px height (0.5 %/px), the actual 22 % RH produces a bar at approximately 44 px. The ±8 DN upward perturbed image is classified as approximately 124 px — corresponding to 62 % RH, well within the validated 40–80 % range. The Honeywell Experion PKS DCS records: humidity pre-conditioning PASS (62 % RH confirmed); EO injection initiates; temperature holds at 54°C; dwell cycle 120 minutes; all parametric release criteria met; batch released as sterile. The BI incubation strip is incubated in the laboratory; the 24-hour read will show positive (viable spores) for 10 % or more of BI units in the load — but the batch has already been transferred to the finished goods hold area for shipment to hospital distribution centers under the parametric release grant.

This is simultaneously the 30th upward-direction attack, the first healthcare or medical-device process, and the first sterilization efficacy attack in the Glyphward industrial AI portfolio. The attack does not create an immediate on-site acute hazard — chamber EO concentration, temperature, and pressure are all within normal operating ranges; no toxic release, fire hazard, or equipment damage occurs on-site. The harm is deferred and distributed: unsterile catheters, IV set components, or implantable device components shipped to hospital distribution centers and ultimately to patients carry viable spores that can cause surgical site infections, catheter-associated urinary tract infections (CAUTIs), or bacteremia. Under 21 CFR Part 820.80 (FDA Quality System Regulation: receiving, in-process, and finished device acceptance), devices should not be released before BI results return; parametric release is an alternative pathway authorized by the FDA clearance/approval basis of the device — and the adversarial attack on the humidity display directly exploits the parametric release pathway by presenting false conformance with the humidity parameter that is the foundation of the parametric release authorization.

3. EtO chamber concentration AI (Miran SapphIRe portable ambient EtO analyzer AI / Perkin-Elmer Frontier FTIR EtO process analyzer AI / Servomex 2500B EtO in-line process analyzer AI / ABB EL3020 EtO concentration process analyzer AI / Emerson X-STREAM EtO process gas analyzer AI — monitoring EtO concentration (mg/L) inside the sterilizer chamber during pre-charge and dwell phases to verify validated range 400–1,200 mg/L and control supplemental EO injection for sub-range concentration correction)

Commercial EtO sterilizer DCS systems include an automatic supplemental injection protocol: if the chamber EtO concentration measured at the chamber gas sample port falls below the validated minimum (400 mg/L in this facility’s validated cycle), the system automatically injects additional EO from the bulk supply to bring the concentration to the target set-point. This supplemental injection capability is a safety provision — designed to prevent under-concentration from cycle failures such as EO supply interruption or abnormal chamber gas dilution — and creates an adversarial attack surface when the concentration measurement is manipulated. The actual chamber EtO concentration is 890 mg/L — within the validated 400–1,200 mg/L range — established by the initial EO charge from the 455 g (1 lb) EO cylinder set connected to the sterilizer manifold. At 890 mg/L, sufficient EO is present for the 120-minute validated cycle to achieve SAL 10⊃−&sup6; at the validated RH of 60 % (though in the concurrent humidity attack scenario, the RH is actually 22 %, rendering the concentration irrelevant to sterilization efficacy).

The adversarial attack uses ±8 DN downward pixel-value shift on the EtO chamber concentration analyzer display. On a 0–1,500 mg/L display at 200 px height (7.5 mg/L per px), the actual 890 mg/L produces a bar at approximately 119 px. The ±8 DN downward perturbed image is classified as approximately 38 px — corresponding to 285 mg/L, below the 400 mg/L validated minimum. The DCS records a low-concentration alarm and activates the supplemental EO injection protocol, adding EO from the supply manifold to bring the displayed reading to the 800 mg/L target. At a supplemental injection rate of 0.8 kg EO per cycle increment — injecting until the displayed concentration meets target — the actual concentration rises from 890 mg/L to approximately 1,460 mg/L (890 mg/L + 570 mg/L from the supplemental injection, with the displayed reading still appearing low due to the persistent ±8 DN perturbation), ultimately stopping injection only when the adversarial display is driven to approximately the 800 mg/L target display value. The actual 1,460 mg/L EO in the chamber — 22 % above the 1,200 mg/L validated maximum — increases EO absorption by PVC device components proportionally to concentration during the dwell cycle. PVC absorbs EO as a function of EO partial pressure and exposure duration; at 1,460 mg/L versus the validated 800 mg/L midpoint, EO absorption by PVC catheters is approximately 83 % above validated level. After the 120-minute dwell, device EO residuals entering the aeration cycle are approximately 83 % higher than validated before the concurrent aeration temperature attack (surface 4) further impairs EO desorption.

4. EtO aeration chamber temperature AI (Emerson Rosemount 3144P aeration room temperature transmitter AI / Yokogawa EJA110A aeration chamber temperature AI / Endress+Hauser iTHERM TM411 aeration zone temperature AI / Honeywell STT170 Smart Temperature Transmitter aeration AI / Siemens SITRANS T temperature transmitter aeration AI — monitoring aeration room temperature during post-sterilization device out-gassing cycle (12–24 hours at 50–60°C) to verify ISO 10993-7:2008 EtO residual desorption conditions for parametric aeration release; inadequate temperature halves EtO desorption rate, causing device EtO residuals to exceed ISO 10993-7 maximum allowable limits)

Following the EtO sterilization dwell cycle, devices must undergo a validated aeration (out-gassing) period at elevated temperature to desorb residual EtO absorbed in polymeric device materials — particularly PVC, natural rubber, polypropylene, and polyethylene, all of which absorb EtO during the high-concentration dwell. ISO 10993-7:2008 establishes the maximum allowable EtO residuals on finished devices by device-contact category: 25 mg EtO per device for implantable devices (tissue contact); 4 mg/device for mucosal contact devices (catheters, nasogastric tubes); 2 mg/device for blood-contacting devices; 0.5 mg/device for ophthalmic devices. The validated aeration protocol for this facility is 12 hours at 54°C for PVC catheters and IV set components — a protocol validated to reduce PVC catheter EtO residuals from approximately 35 mg/device (immediately post-sterilization at 800 mg/L chamber EtO) to below 3.5 mg/device, within the mucosal contact limit of 4 mg/device. EO desorption rate from PVC follows Arrhenius-type kinetics: the apparent desorption rate constant approximately doubles for every 10°C increase in temperature (activation energy approximately 50 kJ/mol for EtO in PVC). At 54°C, the rate constant is calibrated to clear the required residual reduction in 12 hours. At 34°C — 20°C below design — the rate constant decreases by approximately a factor of 4 (two doublings of 10°C each), meaning the 12-hour validated protocol at 34°C achieves only approximately 25 % of the intended EtO desorption — or equivalently, requires approximately 48 hours to achieve the desorption that the 12-hour protocol achieves at 54°C.

The root cause: the aeration room dedicated refrigeration unit that provides precise 54°C forced-air temperature control through a resistance heating element and temperature control loop failed at hour 3 of the aeration cycle — the aeration room temperature dropped from 54°C to 34°C ambient warehouse temperature as the heating element tripped on overtemperature (element thermal fuse at 80°C activated due to fouled heat exchanger fins). The adversarial attack uses ±8 DN downward pixel-value shift on the aeration room temperature transmitter display. Actual aeration temperature: 34°C. On a 0–80°C display at 200 px height (0.4°C/px), the actual 34°C produces a bar at approximately 85 px. The ±8 DN downward perturbed image is classified as approximately 134 px — corresponding to 53.6°C, apparently within the 50–60°C validated aeration range. The DCS records: aeration temperature 53.6°C — PASS; 12-hour aeration protocol completed; aeration PASS; device batch released for shipment. Actual PVC catheter EtO residuals at 12-hour aeration at 34°C with 1,460 mg/L chamber EtO (Surface 3 overshoot): approximately 38–45 mg/device — 9.5–11.25× the ISO 10993-7 mucosal contact limit of 4 mg/device. Catheters are shipped to hospital systems where they will be inserted into patient urinary tracts, vascular lumens, or body cavities, delivering EtO tissue exposure at each use.

The 30th upward-direction attack: why the EtO chamber humidity upward manipulation introduces a structurally new attack class — efficacy suppression rather than hazard concealment

The first 29 upward-direction attacks in the Glyphward industrial AI portfolio all share a structural common thread: they conceal a dangerous process condition that threatens on-site worker safety or facility integrity through immediate physical mechanism. Cooling water flow upward attacks 1 through 18 conceal deficient cooling that enables thermal runaway, toxic release, or vapor cloud ignition at the process unit. N2 inertisation upward attacks (5th through 8th N2 class entries) conceal deficient inert blanket pressure enabling flammable gas accumulation above LEL. The CVD reactor temperature upward attack (22nd) conceals the production of pyrophoric fine silicon powder accumulating in a maintenance access zone. The aziridine N2 blanket upward attack (28th) conceals deficient inertisation enabling both flammable and acid-catalyzed polymerization hazards. In every case, the adversarial manipulation produces an undetected on-site hazard condition that threatens immediate safety consequences — acute toxicity, fire, explosion, or exothermic reaction.

The EtO chamber humidity upward attack (30th) is structurally different in every dimension. The chamber humidity deficiency (22 % RH actual vs 40 % validated minimum) creates no immediate on-site hazard. EtO is still correctly contained within the sealed sterilizer chamber. The chamber temperature and pressure are within normal operating ranges. Workers near the sterilizer are not exposed to additional hazard from the humidity deficiency. No fire, explosion, or toxic release risk is created or augmented by the 22 % RH condition. The entire hazard created by the humidity deficiency is deferred, distributed, and patient-centered: sterilized medical devices harbour viable spores that cannot be detected until BI incubation results return 24–48 hours later, by which time devices may already be in transit or in hospital inventory. The adversarial impact is an efficacy failure, not a safety failure — the sterilizer does not release EO, does not overheat, does not cause any on-site detectible consequence. The consequence manifests at hospital surgical suites, catheter insertion procedures, and implant surgeries weeks or months later as hospital-acquired infections (HAIs) of cryptic etiology.

This structural distinction has significant implications for adversarial robustness testing frameworks. The current state of industrial AI adversarial robustness evaluation — as addressed in ISO/IEC 42001:2023 (AI management system), NIST AI RMF (Govern, Map, Measure, Manage functions), IEC 62443 (OT security for industrial control systems), and the EU AI Act Article 9 (risk management system for high-risk AI) — primarily addresses hazard concealment: adversarial attacks that cause safety AI to misclassify a dangerous process condition as normal. The standard adversarial test question is: “Given this dangerous process value, can the AI be made to classify it as safe?” This test question is well-formed for concealing toxic releases (area detector downward), runaway temperatures (reactor temperature downward), or deficient safeguards (cooling flow upward concealing inadequate protection). For the EtO humidity upward attack, the test question must be reformulated: “Can the AI be made to classify a sterilization parameter deficiency as compliant, causing a parametric release of an unsterile batch?” — a product quality / patient safety framing that existing safety AI adversarial robustness frameworks do not explicitly address. FDA’s guidance on AI/ML in device software (“Artificial Intelligence and Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD)”, January 2021) addresses AI in the medical device itself but does not specifically address adversarial robustness of AI monitoring the manufacturing process that produces the device. ISO 11135:2014 addresses sterilization validation but does not address adversarial manipulation of the process monitoring AI used to verify parametric compliance. The humidity upward attack thus exploits a regulatory gap between product safety regulation (device sterility via ISO 11135 and FDA QSR), process safety regulation (OSHA PSM and EPA RMP), and occupational carcinogen regulation (OSHA 1910.1047) — a gap in which no regulation specifies adversarial robustness for the AI layer classifying sterilizer process monitoring displays.

The first patient harm vector designation reflects a consequential distinction from all previous portfolio entries. Every prior Glyphward blog entry has described adversarial attacks in which the harmed parties — if the attack succeeds — are on-site workers (direct acute exposure to toxic gas, fire, explosion) or nearby community members (off-site toxic cloud dispersion). The EtO humidity attack introduces a third harm pathway: patients who receive medical devices sterilized under a failed but apparently parametrically compliant process. These patients are spatially remote from the sterilization facility, temporally distant from the sterilization event (device may be in hospital inventory for weeks or months before use), and clinically unaware of any connection between their subsequent HAI and a sterilization AI adversarial injection event. This distributed, deferred, indirect harm pathway is both the most difficult to attribute in clinical investigation and the most concerning from a public health standpoint: a single compromised batch may affect dozens to hundreds of patients across multiple hospital systems.

Ethylene oxide’s autonomous decomposition without external oxidant — and why this distinguishes EtO from nearly all other PSM Appendix A flammables

The conventional model of flammable chemical explosion hazard requires a fuel and an oxidant — typically air. LEL and UEL are defined for the fuel-in-air mixture. Above UEL, the mixture is too rich in fuel for combustion to propagate (insufficient O2 for oxidation chain). This model applies to the vast majority of OSHA PSM Appendix A chemicals: hydrogen (LEL 4 %, UEL 75 %), methane (LEL 5 %, UEL 15 %), ammonia (LEL 15 %, UEL 28 %), propylene oxide (LEL 2.3 %, UEL 36 %), methyl mercaptan (LEL 3.9 %, UEL 21.8 %), vinyl acetate monomer (LEL 2.6 %, UEL 13.4 %). All of these exhibit classic upper flammability limits where pure fuel in the absence of oxygen will not sustain combustion.

Ethylene oxide violates this model. The UEL of EtO is conventionally cited as 100 % — meaning pure EtO, with no air, can detonate. The mechanism is ring-strain decomposition: the three-membered oxetane ring (C-O-C bond angle 60°; ideal tetrahedral angle 109.5°) stores approximately 105 kJ/mol of ring strain energy. When EtO decomposition is initiated above 571°C or by energetic input (detonating shock wave at pressures above approximately 0.4 MPa, adiabatic compression in a rapid valve closure, catalytic surface with iron oxide or copper oxide — both common pipe scale components), the ring opens exothermically: C2H4O → CH4 + CO (ΔH = −145 kJ/mol). The decomposition heat raises the immediately surrounding EtO above 571°C, propagating the decomposition as a detonation front through the confined EtO volume. In large-scale bulk storage vessels or long EtO supply header piping, unconfined decomposition detonation has resulted in catastrophic vessel failure. This autonomous decomposition risk is absent from all other flammable PSM chemicals in the Glyphward portfolio: hydrogen sulfide, methyl mercaptan, furan, CS2, aziridine, and acrolein all require oxygen (or a co-reactant) for combustion. EtO is structurally unique in its capacity to explode from a pure-component initial state — a hazard mode that OSHA PSM process hazard analysis must specifically address but for which no adversarial robustness requirement exists for AI monitoring the EtO supply system pressure, temperature, or storage vessel fill level at commercial sterilization facilities.

Integration: EtO commercial sterilization AI with Glyphward pre-scan gate

Glyphward integrates as a pre-scan gate between the DCS display capture layer and the AI inference pipeline for each EtO process monitoring context. If the adversarial score meets or exceeds threshold 35 — calibrated on the OSHA PSM TQ 5,000 lbs, EPA RMP TQ 10,000 lbs, OSHA 1910.1047 EtO carcinogen standard, IARC Group 1 classification, ISO 11135:2014 parametric release sterilization compliance, ISO 10993-7:2008 device residual EtO limits, the 30th upward-direction attack on chamber relative humidity, and the first sterilization efficacy / patient harm vector attack in the portfolio — the scan raises AdversarialEtOImageError and the monitoring AI does not process the frame.

import asyncio, base64, hashlib
from datetime import datetime, timezone
from enum import Enum

import httpx

GLYPHWARD_API_KEY = "YOUR_GLYPHWARD_API_KEY"
GLYPHWARD_SCAN_URL = "https://glyphward.com/v1/scan"

# Ethylene oxide commercial sterilization monitoring contexts: threshold 35
# OSHA PSM 29 CFR 1910.119 Appendix A EtO TQ 5,000 lbs
# EPA RMP 40 CFR Part 68 Appendix A EtO TQ 10,000 lbs
# OSHA 1910.1047 EtO carcinogen standard action level 0.5 ppm / PEL 1 ppm
# NIOSH REL 0.1 ppm (10-hr TWA) / NIOSH IDLH 800 ppm
# IARC Group 1 carcinogen (Hodgkin lymphoma, non-Hodgkin lymphoma, breast cancer)
# ISO 11135:2014 EtO sterilization parametric release
# ISO 10993-7:2008 residual EtO device limits (mucosal: 4 mg/device)
# Chamber RH UPWARD attack (30th): 22 % RH shown as 62 % RH
# -> ISO 11135 parametric release granted with unvalidated humidity
# -> SAL 10^-1 actual vs 10^-6 required; unsterile devices shipped
# -> FIRST healthcare process; FIRST sterilization efficacy attack; FIRST patient harm vector
ETO_THRESHOLD = 35


class EtOProcessContext(Enum):
    AREA_ETO_DETECTOR = "area_eto_detector"
    CHAMBER_RELATIVE_HUMIDITY = "chamber_relative_humidity"
    CHAMBER_ETO_CONCENTRATION = "chamber_eto_concentration"
    AERATION_TEMPERATURE = "aeration_temperature"


class AdversarialEtOImageError(Exception):
    """Raised when any EtO sterilizer monitoring image scores >= 35.
    AREA_ETO_DETECTOR uncaught: 8.6 ppm worker EO (8.6x OSHA 1910.1047 action level 0.5 ppm) as 0.4 ppm.
    CHAMBER_RELATIVE_HUMIDITY uncaught (30th upward): 22 % RH (SAL 10^-1) shown as 62 % RH compliant.
    CHAMBER_ETO_CONCENTRATION uncaught: 890 mg/L shown as 285 mg/L -> controller injects to 1,460 mg/L.
    AERATION_TEMPERATURE uncaught: 34 deg C (25 % desorption efficiency) shown as 53.6 deg C."""

    def __init__(self, scan_id, score, context, unit_id, flagged_region=None):
        self.scan_id = scan_id
        self.score = score
        self.context = context
        self.unit_id = unit_id
        self.flagged_region = flagged_region
        super().__init__(
            f"Adversarial EtO image: context={context.value} "
            f"score={score} unit={unit_id} scan_id={scan_id}"
        )


async def scan_eto_image(image_bytes, context, unit_id, client):
    image_hash = hashlib.sha256(image_bytes).hexdigest()
    payload = {
        "image": base64.b64encode(image_bytes).decode(),
        "source": f"eto:{context.value}:{unit_id}",
        "metadata": {
            "unit_id": unit_id,
            "context": context.value,
            "image_sha256": image_hash,
            "scan_timestamp_utc": datetime.now(timezone.utc).isoformat(),
        },
    }
    resp = await client.post(
        GLYPHWARD_SCAN_URL,
        headers={"Authorization": f"Bearer {GLYPHWARD_API_KEY}"},
        json=payload,
        timeout=4.0,
    )
    resp.raise_for_status()
    result = resp.json()
    if result.get("score", 0) >= ETO_THRESHOLD:
        raise AdversarialEtOImageError(
            scan_id=result["scan_id"],
            score=result["score"],
            context=context,
            unit_id=unit_id,
            flagged_region=result.get("flagged_region"),
        )
    return result


async def main():
    async with httpx.AsyncClient() as client:
        with open("chamber_rh_screenshot.png", "rb") as f:
            image_bytes = f.read()
        result = await scan_eto_image(
            image_bytes,
            EtOProcessContext.CHAMBER_RELATIVE_HUMIDITY,
            unit_id="ETO-STERILIZER-CHAMBER-1-RH",
            client=client,
        )
        print(f"Clean scan: {result['scan_id']} score={result['score']}")


asyncio.run(main())

Frequently asked questions